haleon uk trading limited
haleon uk trading limited Company Information
Company Number
09237643
Website
http://maxinutrition.comRegistered Address
building 5, first floor, the heights, weybridge, surrey, KT13 0NY
Industry
Manufacture of pharmaceutical preparations
Telephone
02080475000
Next Accounts Due
September 2024
Group Structure
View All
Shareholders
haleon uk holdings (no.3) limited 100%
haleon uk trading limited Estimated Valuation
Pomanda estimates the enterprise value of HALEON UK TRADING LIMITED at £3.2b based on a Turnover of £1.1b and 2.9x industry multiple (adjusted for size and gross margin).
haleon uk trading limited Estimated Valuation
Pomanda estimates the enterprise value of HALEON UK TRADING LIMITED at £1.2b based on an EBITDA of £87.8m and a 13.26x industry multiple (adjusted for size and gross margin).
haleon uk trading limited Estimated Valuation
Pomanda estimates the enterprise value of HALEON UK TRADING LIMITED at £991.1m based on Net Assets of £456.9m and 2.17x industry multiple (adjusted for liquidity).
Edit your figures and get a professional valuation report.
Haleon Uk Trading Limited AI Business Plan
In just minutes, we combine Pomanda’s company and industry data with cutting edge Artificial Intelligence to build a comprehensive 27 section business plan. You then have 60 days to tailor the information, decide which sections to include or exclude, and add your own branding logos, images and color scheme to create your perfect plan.
Haleon Uk Trading Limited Overview
Haleon Uk Trading Limited is a live company located in weybridge, KT13 0NY with a Companies House number of 09237643. It operates in the manufacture of pharmaceutical preparations sector, SIC Code 21200. Founded in September 2014, it's largest shareholder is haleon uk holdings (no.3) limited with a 100% stake. Haleon Uk Trading Limited is a established, mega sized company, Pomanda has estimated its turnover at £1.1b with low growth in recent years.
Upgrade for unlimited company reports & a free credit check
Haleon Uk Trading Limited Health Check
Pomanda's financial health check has awarded Haleon Uk Trading Limited a 4.5 rating. We use a traffic light system to show it exceeds the industry average on 8 measures and has 4 areas for improvement. Company Health Check FAQs
8 Strong
0 Regular
4 Weak
Size
annual sales of £1.1b, make it larger than the average company (£23.9m)
£1.1b - Haleon Uk Trading Limited
£23.9m - Industry AVG
Growth
3 year (CAGR) sales growth of 4%, show it is growing at a faster rate (1.9%)
4% - Haleon Uk Trading Limited
1.9% - Industry AVG
Production
with a gross margin of 66.7%, this company has a lower cost of product (34.9%)
66.7% - Haleon Uk Trading Limited
34.9% - Industry AVG
Profitability
an operating margin of 3.9% make it less profitable than the average company (5.6%)
3.9% - Haleon Uk Trading Limited
5.6% - Industry AVG
Employees
with 1505 employees, this is above the industry average (106)
1505 - Haleon Uk Trading Limited
106 - Industry AVG
Pay Structure
on an average salary of £147.5k, the company has a higher pay structure (£54.5k)
£147.5k - Haleon Uk Trading Limited
£54.5k - Industry AVG
Efficiency
resulting in sales per employee of £734.8k, this is more efficient (£278.1k)
£734.8k - Haleon Uk Trading Limited
£278.1k - Industry AVG
Debtor Days
it gets paid by customers after 31 days, this is earlier than average (62 days)
31 days - Haleon Uk Trading Limited
62 days - Industry AVG
Creditor Days
its suppliers are paid after 150 days, this is slower than average (38 days)
150 days - Haleon Uk Trading Limited
38 days - Industry AVG
Stock Days
it holds stock equivalent to 2 days, this is less than average (102 days)
2 days - Haleon Uk Trading Limited
102 days - Industry AVG
Cash Balance
has cash to cover current liabilities for 0 weeks, this is less cash available to meet short term requirements (10 weeks)
0 weeks - Haleon Uk Trading Limited
10 weeks - Industry AVG
Debt Level
it has a ratio of liabilities to total assets of 51.1%, this is a higher level of debt than the average (44.3%)
51.1% - Haleon Uk Trading Limited
44.3% - Industry AVG
haleon uk trading limited Credit Report and Business Information
Haleon Uk Trading Limited Competitor Analysis
Perform a competitor analysis for haleon uk trading limited by selecting its closest rivals and benchmarking them against 12 key performance metrics.
haleon uk trading limited Ownership
HALEON UK TRADING LIMITED group structure
Haleon Uk Trading Limited has no subsidiary companies.
Ultimate parent company
2 parents
HALEON UK TRADING LIMITED
09237643
haleon uk trading limited directors
Haleon Uk Trading Limited currently has 5 directors. The longest serving directors include Antrinkos Aristidou (Aug 2019) and Mr Nicholas Cooper (Sep 2019).
| officer | country | age | start | end | role |
|---|---|---|---|---|---|
| Antrinkos Aristidou | England | 56 years | Aug 2019 | - | Director |
| Mr Nicholas Cooper | England | 51 years | Sep 2019 | - | Director |
| Mr Nicholas Cooper | England | 51 years | Sep 2019 | - | Director |
| Mr Gueorgui Roussev | England | 48 years | Jul 2020 | - | Director |
| Mrs Oriane Lacaze | England | 45 years | Feb 2022 | - | Director |
HALEON UK TRADING LIMITED financials
Haleon Uk Trading Limited's latest turnover from December 2022 is £1.1 billion and the company has net assets of £456.9 million. According to their latest financial statements, Haleon Uk Trading Limited has 1,505 employees and maintains cash reserves of £4.7 million as reported in the balance sheet.
Data source: Companies House, Pomanda Estimates
| Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | Dec 2017 | Dec 2016 | Dec 2015 | |
|---|---|---|---|---|---|---|---|---|
| Turnover | 1,105,863,000 | 1,098,337,000 | 889,445,000 | 993,623,000 | 982,723,000 | 907,175,000 | 771,060,000 | 631,846,000 |
| Other Income Or Grants | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Cost Of Sales | 367,985,000 | 355,544,000 | 346,733,000 | 576,687,000 | 527,761,000 | 524,999,000 | 415,060,000 | 339,190,000 |
| Gross Profit | 737,878,000 | 742,793,000 | 542,712,000 | 416,936,000 | 454,962,000 | 382,176,000 | 356,000,000 | 292,656,000 |
| Admin Expenses | 695,144,000 | 694,199,000 | 510,989,000 | 384,599,000 | 392,770,000 | 352,093,000 | 315,916,000 | 264,042,000 |
| Operating Profit | 42,734,000 | 48,594,000 | 31,723,000 | 32,337,000 | 62,192,000 | 30,083,000 | 40,084,000 | 28,614,000 |
| Interest Payable | 427,000 | 108,000 | 822,000 | 1,062,000 | 1,207,000 | 382,000 | 1,529,000 | 105,000 |
| Interest Receivable | 1,094,000 | 0 | 58,000 | 575,000 | 229,000 | 59,000 | 13,000 | 17,000 |
| Pre-Tax Profit | 43,401,000 | 35,654,000 | 34,981,000 | 31,850,000 | 61,214,000 | 29,760,000 | 38,568,000 | 28,526,000 |
| Tax | -11,262,000 | -5,084,000 | -5,963,000 | -6,358,000 | -5,880,000 | -4,370,000 | -8,118,000 | -6,537,000 |
| Profit After Tax | 32,139,000 | 30,570,000 | 29,018,000 | 25,492,000 | 55,334,000 | 25,390,000 | 30,450,000 | 21,989,000 |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Retained Profit | 32,139,000 | 30,570,000 | 29,018,000 | 25,492,000 | 55,334,000 | 25,390,000 | 30,450,000 | 21,989,000 |
| Employee Costs | 221,947,000 | 254,598,000 | 191,941,000 | 213,053,000 | 154,833,000 | 161,063,000 | 108,648,000 | 109,682,000 |
| Number Of Employees | 1,505 | 1,592 | 1,609 | 1,459 | 1,389 | 1,379 | 1,190 | 1,229 |
| EBITDA* | 87,807,000 | 81,347,000 | 73,409,000 | 64,692,000 | 113,394,000 | 60,751,000 | 58,851,000 | 43,216,000 |
* Earnings Before Interest, Tax, Depreciation and Amortisation
| Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | Dec 2017 | Dec 2016 | Dec 2015 | |
|---|---|---|---|---|---|---|---|---|
| Tangible Assets | 109,950,000 | 102,974,000 | 99,026,000 | 99,468,000 | 104,436,000 | 120,719,000 | 121,263,000 | 126,518,000 |
| Intangible Assets | 165,042,000 | 164,326,000 | 150,791,000 | 106,653,000 | 96,192,000 | 46,811,000 | 41,384,000 | 31,443,000 |
| Investments & Other | 0 | 4,348,000 | 3,335,000 | 10,067,000 | 4,094,000 | 3,691,000 | 0 | 0 |
| Debtors (Due After 1 year) | 3,497,000 | 9,228,000 | 9,193,000 | 6,646,000 | 0 | 0 | 0 | 5,078,000 |
| Total Fixed Assets | 278,489,000 | 280,876,000 | 262,345,000 | 222,834,000 | 204,722,000 | 171,221,000 | 162,647,000 | 163,039,000 |
| Stock & work in progress | 2,527,000 | 2,554,000 | 2,832,000 | 29,173,000 | 26,509,000 | 57,550,000 | 8,119,000 | 10,827,000 |
| Trade Debtors | 96,490,000 | 80,069,000 | 72,045,000 | 126,504,000 | 129,841,000 | 126,132,000 | 77,417,000 | 60,204,000 |
| Group Debtors | 497,967,000 | 363,297,000 | 659,243,000 | 403,250,000 | 290,799,000 | 306,875,000 | 294,275,000 | 421,399,000 |
| Misc Debtors | 54,324,000 | 24,363,000 | 26,450,000 | 17,012,000 | 7,922,000 | 0 | 895,000 | 3,894,000 |
| Cash | 4,730,000 | 4,962,000 | 1,000 | 6,709,000 | 10,775,000 | 6,386,000 | 2,473,000 | 689,000 |
| misc current assets | 0 | 0 | 127,011,000 | 25,992,000 | 25,402,000 | 17,712,000 | 1,162,000 | 3,062,000 |
| total current assets | 656,038,000 | 475,245,000 | 887,582,000 | 608,640,000 | 491,248,000 | 514,655,000 | 384,341,000 | 500,075,000 |
| total assets | 934,527,000 | 756,121,000 | 1,149,927,000 | 831,474,000 | 695,970,000 | 685,876,000 | 546,988,000 | 663,114,000 |
| Bank overdraft | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 5,929,000 |
| Bank loan | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Trade Creditors | 151,690,000 | 75,815,000 | 86,379,000 | 114,876,000 | 83,602,000 | 52,844,000 | 67,920,000 | 58,942,000 |
| Group/Directors Accounts | 98,042,000 | 94,441,000 | 426,794,000 | 121,756,000 | 172,091,000 | 244,045,000 | 155,780,000 | 327,504,000 |
| other short term finances | 270,000 | 356,000 | 0 | 29,000 | 3,039,000 | 0 | 5,612,000 | 0 |
| hp & lease commitments | 0 | 0 | 357,000 | 0 | 0 | 3,900,000 | 0 | 0 |
| other current liabilities | 214,001,000 | 145,931,000 | 268,471,000 | 222,235,000 | 160,680,000 | 155,465,000 | 123,670,000 | 98,138,000 |
| total current liabilities | 464,003,000 | 316,543,000 | 782,001,000 | 458,896,000 | 419,412,000 | 456,254,000 | 352,982,000 | 490,513,000 |
| loans | 512,000 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| hp & lease commitments | 0 | 0 | 350,000 | 0 | 0 | 4,200,000 | 6,300,000 | 8,400,000 |
| Accruals and Deferred Income | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| other liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| provisions | 13,088,000 | 29,240,000 | 11,463,000 | 58,362,000 | 19,974,000 | 24,172,000 | 5,399,000 | 11,260,000 |
| total long term liabilities | 13,600,000 | 29,240,000 | 11,813,000 | 58,362,000 | 19,974,000 | 28,372,000 | 11,699,000 | 19,660,000 |
| total liabilities | 477,603,000 | 345,783,000 | 793,814,000 | 517,258,000 | 439,386,000 | 484,626,000 | 364,681,000 | 510,173,000 |
| net assets | 456,924,000 | 410,338,000 | 356,113,000 | 314,216,000 | 256,584,000 | 201,250,000 | 182,307,000 | 152,941,000 |
| total shareholders funds | 456,924,000 | 410,338,000 | 356,113,000 | 314,216,000 | 256,584,000 | 201,250,000 | 182,307,000 | 152,941,000 |
| Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | Dec 2017 | Dec 2016 | Dec 2015 | |
|---|---|---|---|---|---|---|---|---|
| Operating Activities | ||||||||
| Operating Profit | 42,734,000 | 48,594,000 | 31,723,000 | 32,337,000 | 62,192,000 | 30,083,000 | 40,084,000 | 28,614,000 |
| Depreciation | 12,598,000 | 6,857,000 | 14,917,000 | 12,648,000 | 26,865,000 | 21,403,000 | 11,362,000 | 9,649,000 |
| Amortisation | 32,475,000 | 25,896,000 | 26,769,000 | 19,707,000 | 24,337,000 | 9,265,000 | 7,405,000 | 4,953,000 |
| Tax | -11,262,000 | -5,084,000 | -5,963,000 | -6,358,000 | -5,880,000 | -4,370,000 | -8,118,000 | -6,537,000 |
| Stock | -27,000 | -278,000 | -26,341,000 | 2,664,000 | -31,041,000 | 49,431,000 | -2,708,000 | 10,827,000 |
| Debtors | 175,321,000 | -289,974,000 | 213,519,000 | 124,850,000 | -4,445,000 | 60,420,000 | -117,988,000 | 490,575,000 |
| Creditors | 75,875,000 | -10,564,000 | -28,497,000 | 31,274,000 | 30,758,000 | -15,076,000 | 8,978,000 | 58,942,000 |
| Accruals and Deferred Income | 68,070,000 | -122,540,000 | 46,236,000 | 61,555,000 | 5,215,000 | 31,795,000 | 25,532,000 | 98,138,000 |
| Deferred Taxes & Provisions | -16,152,000 | 17,777,000 | -46,899,000 | 38,388,000 | -4,198,000 | 18,773,000 | -5,861,000 | 11,260,000 |
| Cash flow from operations | 29,044,000 | 251,188,000 | -148,892,000 | 62,037,000 | 174,775,000 | -17,978,000 | 200,078,000 | -296,383,000 |
| Investing Activities | ||||||||
| capital expenditure | ||||||||
| Change in Investments | -4,348,000 | 1,013,000 | -6,732,000 | 5,973,000 | 403,000 | 3,691,000 | 0 | 0 |
| cash flow from investments | ||||||||
| Financing Activities | ||||||||
| Bank loans | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Group/Directors Accounts | 3,601,000 | -332,353,000 | 305,038,000 | -50,335,000 | -71,954,000 | 88,265,000 | -171,724,000 | 327,504,000 |
| Other Short Term Loans | -86,000 | 356,000 | -29,000 | -3,010,000 | 3,039,000 | -5,612,000 | 5,612,000 | 0 |
| Long term loans | 512,000 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Hire Purchase and Lease Commitments | 0 | -707,000 | 707,000 | 0 | -8,100,000 | 1,800,000 | -2,100,000 | 8,400,000 |
| other long term liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| share issue | ||||||||
| interest | 667,000 | -108,000 | -764,000 | -487,000 | -978,000 | -323,000 | -1,516,000 | -88,000 |
| cash flow from financing | 19,141,000 | -309,157,000 | 317,831,000 | -21,692,000 | -77,993,000 | 77,683,000 | -170,812,000 | 466,768,000 |
| cash and cash equivalents | ||||||||
| cash | -232,000 | 4,961,000 | -6,708,000 | -4,066,000 | 4,389,000 | 3,913,000 | 1,784,000 | 689,000 |
| overdraft | 0 | 0 | 0 | 0 | 0 | 0 | -5,929,000 | 5,929,000 |
| change in cash | -232,000 | 4,961,000 | -6,708,000 | -4,066,000 | 4,389,000 | 3,913,000 | 7,713,000 | -5,240,000 |
P&L
December 2022turnover
1.1b
+1%
operating profit
42.7m
-12%
gross margin
66.8%
-1.34%
turnover
Turnover, or revenue, is the amount of sales generated by a company within the financial year.
Balance Sheet
December 2022net assets
456.9m
+0.11%
total assets
934.5m
+0.24%
cash
4.7m
-0.05%
net assets
Total assets minus all liabilities
Similar Companies
haleon uk trading limited company details
company number
09237643
Type
Private limited with Share Capital
industry
21200 - Manufacture of pharmaceutical preparations
incorporation date
September 2014
age
10
accounts
Full Accounts
ultimate parent company
previous names
glaxosmithkline consumer healthcare (uk) trading limited (February 2023)
incorporated
UK
address
building 5, first floor, the heights, weybridge, surrey, KT13 0NY
last accounts submitted
December 2022
haleon uk trading limited Charges & Mortgages
A charge, or mortgage, refers to the rights a company gives to a lender in return for a loan, often in the form of security given over business assets.
We did not find charges/mortgages relating to haleon uk trading limited.
haleon uk trading limited Companies House Filings - See Documents
| date | description | view/download |
|---|
